7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Campbell Pinned to Neutral

by Zacks Equity Research

October 03, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We are maintaining our long-term Neutral recommendation on New Jersey based Campbell Soup Company ( CPB - Analyst Report ) .

Campbell recently reported its fourth quarter and fiscal 2012 results (ended July 2012). Going with its strategy of brand expansion and cost management, the company reported better-than-expected quarterly results.

Its reported net sales of $1,613 million for the quarter were higher than the prior-quarter level as well as Zacks Consensus Estimate. Moreover, quarterly earnings of 41 cents per share were also ahead of the Zacks Consensus Estimate of 38 cents.

Further, the company anticipates an improvement in sales in the range of 10%–12% for the fiscal 2013, with annual earnings to lie between $2.51 and $2.57 per share, reflecting an increase of 3%–5% from 2012 level.

Going forward, the company’s recent Bolthouse acquisition will prove to be accretive to its fiscal 2013 top and bottom line. In addition, the company intends to boost its top line and increase return on investment through a new strategic framework, primarily focusing on brand expansion, and thereby plans to launch nearly 50 new products in fiscal 2013 while emphasizing on brand advertisement and consumer promotional activities.

We believe that Campbell’s prudent investment and strategic initiatives toward product innovation and brand building will lead to an increase in its customer base and profitability. Moreover, the company’s continuous focus on research and development to further differentiate its higher-margin sauces brands will strengthen its competitive position in the international market.

On the flip side, rising commodity costs, intense competition from other established players and exposure to unfavorable foreign currency fluctuations may undermine the company’s growth prospects.

Due to its exposure in international market, Campbell Soup remains prone to currency fluctuations, which remains a major reason for continuous decline in its International Simple Meals and Beverages segment. Sales at this segment declined 7.0% to $294.0 million in the fourth quarter 2012, primarily due to a 4% rise in promotional spending and 8% negative impact from currency translation.

Moreover, Campbell operates in a highly competitive food industry and experiences worldwide competition in all its principal products from well-established rivals like General Mills Inc. ( GIS - Analyst Report ) , H. J. Heinz Co. ( HNZ - Analyst Report ) , which may dent the company’s performance going forward.

Considering these above factors, we think that the investors should wait to own this stock until its strategic initiatives and turnaround plans reflect better visibility.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.